Literature DB >> 2307518

The 96-kilodalton antigen as an integral membrane protein in pathogenic Entamoeba histolytica: potential differences in pathogenic and nonpathogenic isolates.

B E Torian1, S L Reed, B M Flores, C M Creely, J E Coward, K Vial, W E Stamm.   

Abstract

A surface antigen (EH-96) of Entamoeba histolytica was demonstrated to be a plasma membrane antigen by immunoprecipitation of metabolically 35S-labeled antigen from live trophozoites, Triton X-114 detergent extracts, and plasma membrane-enriched fractions prepared by concanavalin A membrane stabilization and differential centrifugation. In addition, the antigen was localized to the plasma membrane by electron microscopy with colloidal gold. Antigen from E. histolytica strains immunoprecipitated with specific immunoglobulin M (IgM) or IgG2b monoclonal antibody was identical by one-dimensional peptide mapping with N-chlorosuccinimide. Additionally, antigen from different axenically cultivated amebae was demonstrated to be identical by N-chlorosuccinimide peptide mapping, as were peptide maps of IgG and IgM monoclonal antibody-purified antigen. The 96-kilodalton (kDa) surface antigen was identified on four axenically cultivated pathogenic isolates and on three polyxenically cultivated pathogenic isolates (zymodeme II) of E. histolytica but was absent or present in lesser quantity on six nonpathogenic polyxenically cultivated isolates. The 96-kDa antigen was detected in liver abscess fluid from four patients with amebic abscesses by enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation. Two-dimensional gel electrophoresis profiles of the 96-kDa antigen purified from abscess material or from polyxenically cultivated trophozoites demonstrated that the antigens were related to the 96-kDa antigen found in axenically cultivated organisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307518      PMCID: PMC258529          DOI: 10.1128/iai.58.3.753-760.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  High resolution two-dimensional electrophoresis of basic as well as acidic proteins.

Authors:  P Z O'Farrell; H M Goodman; P H O'Farrell
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis.

Authors:  P G Sargeaunt; J E Williams; J D Grene
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

4.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  The laboratory diagnosis of human parasitic amoebae.

Authors:  G L Robinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1968       Impact factor: 2.184

7.  Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes.

Authors:  J Bouvier; R J Etges; C Bordier
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

8.  Amoebic antigen in immunodiagnosis and prognosis of amoebic liver abscess.

Authors:  R C Mahajan; N K Ganguly
Journal:  Trans R Soc Trop Med Hyg       Date:  1980       Impact factor: 2.184

9.  Cytopathogenic mechanisms of Entamoeba histolytica.

Authors:  J I Ravdin; B Y Croft; R L Guerrant
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

10.  Plasma membrane of Entamoeba histolytica.

Authors:  S B Aley; W A Scott; Z A Cohn
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

View more
  8 in total

1.  Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

Authors:  H Tachibana; S Kobayashi; Y Kaneda; T Takeuchi; T Fujiwara
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

Authors:  H Tachibana; X J Cheng; K Watanabe; M Takekoshi; F Maeda; S Aotsuka; Y Kaneda; T Takeuchi; S Ihara
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Nucleotide sequence of a small subunit ribosomal RNA (16S-like rRNA) gene from Entamoeba histolytica: differentiation of pathogenic from nonpathogenic isolates.

Authors:  X Que; S L Reed
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

4.  cDNA sequence analysis of a 29-kDa cysteine-rich surface antigen of pathogenic Entamoeba histolytica.

Authors:  B E Torian; B M Flores; V L Stroeher; F S Hagen; W E Stamm
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 5.  Amebiasis.

Authors:  D A Bruckner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

6.  Molecular and cellular characterization of the 29-kilodalton peripheral membrane protein of Entamoeba histolytica: differentiation between pathogenic and nonpathogenic isolates.

Authors:  S L Reed; B M Flores; M A Batzer; M A Stein; V L Stroeher; J E Carlton; D L Diedrich; B E Torian
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Genetic differentiation of pathogenic and nonpathogenic strains of Entamoeba histolytica by random amplified polymorphic DNA polymerase chain reaction.

Authors:  U Mackenstedt; A M Johnson
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

8.  Characterization of an immuno-dominant variable surface antigen from pathogenic and nonpathogenic Entamoeba histolytica.

Authors:  U Edman; M A Meraz; S Rausser; N Agabian; I Meza
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.